Incidence and outcomes of secondary infections in septic patients with cancer

Shi-ning Qu, Hai-jun Wang, Chu-lin Huang, Hao Zhang, Hao Wang, Zhen-nan Yuan, Xue-zhong Xing

Table 1. Comparison of clinical characteristics between sepsis patients with secondary infections and those who did not develop secondary infections

Clinical variables Non-secondary infections (n=147) Secondary infections (n=14) P-value Age, years 63 (14) 63 (14) 0.488 Male 114 (77.6) 10 (71.4) 0.603 Modified Charlson’s score 2 (1) 2 (0) 0.868 APACHE II 11 (7) 8 (8) 0.008 SAPS 3 52.50 (15.00) 47.50 (13.00) 0.118 SOFA 4.00 (4.00) 3.50 (1.00) 0.143 Radio/chemotherapy 50 (34.0) 3 (21.4) 0.338 AJCC tumor staging 0.804 Stage I/II 59 (39.5) 6 (42.9) Stage III/IV 89 (60.5) 8 (57.1) Immunosuppression at ICU admission 93 (63.3) 8 (57.1) 0.651 NLR at ICU admission 17.29 (19.70) 16.70 (12.01) 0.666 Septic shock 58 (39.5) 3 (21.4) 0.184